Comparison of usability between microcatheter and micro-balloon catheter in superselective transcatheter arterial chemoembolization for hepatocellular carcinoma

Comparison of usability between microcatheter and micro-balloon catheter in superselective transcatheter arterial chemoembolization for hepatocellular carcinoma - Comparison of usability between microcatheter and micro-balloon catheter in superselective TACE for HCC

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025837

Enrollment

Registered

2017-03-01

Start date

2017-02-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma

Interventions

Micro-balloon catheter Microcatheter

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients with histologically or radiographically diagnosed HCC 2)Liver function Child-Pugh A or B 3)BCLC class A or B 4)patients over 20 years old 5)Tumor borden is within the Milan criteria.

Exclusion criteria

Exclusion criteria: 1)No appearance of tumor stain on DSA or Cone beam CT 2)Sever drug allergy 3)No appearance of sub-segmental hepatic artery on DSA 4)Patients with four or more HCC

Design outcomes

Primary

Measure	Time frame
Success rate of superselective TACE	—

Secondary

Measure	Time frame
Distribution of Lipiodol after TACE Accumulation of Lipiodol one week after TACE Complication	—

Countries

Japan

Contacts

Public ContactMasaki Ishikawa

National Hospital Organization, Kure Medicak Center and Chugoku Cancer Center Department of Diagnostic Radiology

ishikawam@kure-nh.go.jp0823-22-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026